01Active phase: Concept feasibility
Concept feasibility
Scientific assessment of new product concepts, formulations and delivery formats.
Discuss this phase →
02 / Innovation & NPD
Make the science earn its place in the pipeline.
Assess ingredients, mechanisms and emerging technologies early, so promising concepts move forward with a credible scientific foundation and weak ones are challenged before they become expensive.
02
Senior-led
Medical Affairs
DECISION → EVIDENCE → ACTION
“Pressure-test the science while the product and proposition are still flexible.”
About this service
Scientific judgement while the concept is still flexible
Assess ingredients, mechanisms and emerging technologies early, so promising concepts move forward with a credible scientific foundation and weak ones are challenged before they become expensive.
Your team has a promising concept, formulation or ingredient but needs an independent view on whether the science stacks up.
Built for
R&D leads
Innovation teams
Brand managers
Regulatory Affairs
What we deliver
Focused outputs, built for the next decision.
Senior scientific input is translated into clear, usable outputs for cross-functional teams.
01
Concept feasibility
Scientific assessment of new product concepts, formulations and delivery formats.
02
Ingredient evaluation
A structured review of ingredient credibility, mechanisms and quality of evidence.
03
Evidence gap analysis
A clear view of what is known, what is missing and what matters before launch.
04
Scientific narrative
A commercially useful story that differentiates the concept without overclaiming.
Commercial impact
Senior judgement that leaves the next decision clearer.
The value is not more process. It is a proportionate scientific route, fewer late surprises and outputs that cross-functional teams can use.
✓ Direct, decision-ready support for r&d leads.
✓ Direct, decision-ready support for innovation teams.
✓ Direct, decision-ready support for brand managers.
✓ Direct, decision-ready support for regulatory affairs.
How we work together.
A focused, senior-led route from the first question to a practical output your team can use.
02Active phase: Ingredient evaluation
Ingredient evaluation
A structured review of ingredient credibility, mechanisms and quality of evidence.
Discuss this phase →
03Active phase: Evidence gap analysis
Evidence gap analysis
A clear view of what is known, what is missing and what matters before launch.
Discuss this phase →
FAQ
Questions about this service.
What does this service cover?
Concept feasibility, Ingredient evaluation, Evidence gap analysis, Scientific narrative. Scope is tailored to the decision and evidence available.
Can this be commissioned as a focused project?
Yes. It can be a defined project or connected into retained senior medical affairs support.
Who leads the work?
Every engagement is senior-led, with direct access to the person shaping the scientific judgement and recommendation.
Related services
Connect the next part of the pathway.
MA
Medical Affairs Strategy
Connect evidence priorities, positioning and lifecycle decisions to the commercial plan.
Explore service →CE
Claims, RWE & Publications
Build defensible claims, evidence plans and publication-ready scientific narratives.
Explore service →RS
Regulatory & Scientific Support
Navigate classification, claims and evidence requirements with practical scientific guidance.
Explore service →